Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Kenneth Cunningham currently holds 72,000 shares of Verona Pharma plc (VRNA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Kenneth Cunningham has been a net seller of VRNA stock. They have purchased $0 and sold $166.0K worth of shares.
Kenneth Cunningham's most recent insider trade was on Oct 7, 2025, when they sold 72,000 shares at $0.00 per share.
Kenneth Cunningham serves as Executive at Verona Pharma plc (VRNA). They have executed 8 insider transactions totaling $166.0K over their tenure at the company.
Kenneth Cunningham holds the position of Executive at Verona Pharma plc, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 5 years and currently hold a stake valued at $0.
Kenneth Cunningham has shown a selling trading pattern, with $0 in total purchases and $166.0K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Kenneth Cunningham was on Aug 1, 2025, when they sold $142.0K worth of VRNA shares. This transaction involved 10,808 shares at $13.14 per share.
Kenneth Cunningham currently owns 72,000 shares of Verona Pharma plc (VRNA), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Kenneth Cunningham's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Kenneth Cunningham has 8 Form 4 filings on record as an insider at Verona Pharma plc.
Set alerts for Kenneth Cunningham and 40,000+ other insiders.